Feb 27 (Reuters) - Teleflex ( TFX ) said on Thursday it

would split into two by spinning off its business that makes

devices for the urology, and acute care markets as well as its

contract manufacturing unit.

That would make Teleflex ( TFX ) a company that primarily makes

devices for bloodstream- and heart-related procedures and for

medical imaging and surgical purposes.

To boost this business, Teleflex ( TFX ) also said it would buy

Germany-based Biotronik's blood vessel device unit for about 760

million euros ($796.3 million) in cash.

Teleflex ( TFX ) said it would distribute shares of the spun-off

company to shareholders and expects the separation to be

completed in mid-2026.

($1 = 0.9544 euros)